Example: Heart Attack

Clinical Trials on Transitional Cell Carcinoma

Total 702 results

NCT04295967

Not yet recruiting

Vasculogenic Mimicry in Urothelial Carcinoma

Conditions: Urothelial Carcinoma
NCT01668459

Completed

Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel

Conditions: Transitional Cell Carcinoma
NCT04314245

Recruiting

Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma

Conditions: Urothelial Carcinoma; Bladder Cancer
NCT03788746

Recruiting

Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma

Conditions: Urothelial Carcinoma
NCT01599013

Completed

JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Carboplatin

Conditions: Bladder Transitional Cell Carcinoma Stage IV
NCT03256877

Completed

Detecting Transitional Cell Carcinoma From Haematuria

Conditions: Transitional Cell Carcinoma
NCT00706641

Completed

Neoadjuvant Dasatinib and Radical Cystectomy for Transitional Cell Carcinoma of the Bladder

Conditions: Transitional Cell Carcinoma of the Bladder
NCT01551030

Completed

Buparlisib in Metastatic Transitional Cell Carcinoma of the Urothelium

Conditions: Metastatic Transitional Cell Carcinoma of the Urothelium
NCT01071928

Withdrawn

Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma

Conditions: Urothelial Carcinoma
NCT02662309

Active, not recruiting

Preoperative MPDL3280A in Transitional Cell Carcinoma of the Bladder

Conditions: Bladder Cancer
NCT03219775

Recruiting

Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma

Conditions: Transitional Cell Carcinoma; Advanced Cancer; Metastatic Cancer
NCT00191971

Completed

2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen

Conditions: Urologic Neoplasms; Carcinoma, Transitional Cell
NCT00389155

Completed

First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

Conditions: Bladder Cancer; Transitional Cell Carcinoma; Metastasis
NCT04432909

Recruiting

A Prospective, Multi-centre, Single-blinded Study of UroCAD for Urothelial Carcinoma Diagnosis and Follow-up

Conditions: Urothelial Carcinoma
NCT00173862

Completed

Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC

Conditions: Transitional Cell Carcinoma
NCT00154687

Completed

Weekly TP-HDFL in the Treatment of Advanced TCC

Conditions: Transitional Cell Carcinoma
NCT01378052

Unknown status

DNA Methylation and Urothelial Carcinoma

Conditions: Urothelial Carcinoma
NCT03430687

Withdrawn

Talimogene Laherparepvec in Treating Patients With Non-Muscle Invasive Bladder Transitional Cell Carcinoma

Conditions: Stage 0 Bladder Urothelial Carcinoma AJCC v6 and v7; Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7; Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7; Stage I Bladder Urothelial Carcinoma AJCC v6 and v7
NCT01830231

Unknown status

Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)

Conditions: Urothelium Transitional Cell Carcinoma
NCT01360723

Unknown status

DNA Methylation and Arsenic-associated Urothelial Carcinoma

Conditions: Urothelial Carcinoma
NCT00694798

Completed

Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder

Conditions: Bladder Cancer
NCT02723838

Withdrawn

Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the Bladder

Conditions: Muscle-invasive Transitional Cell Carcinoma of the Bladder
NCT04486781

Recruiting

A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma

Conditions: Metastatic Urothelial Carcinoma
NCT02326909

Completed

Diagnostic Accuracy of Optical Coherence Tomography in Upper Urinary Tract Urothelial Carcinoma

Conditions: Transitional Cell Carcinoma of Urinary Tract
NCT01189838

Unknown status

The Expression and Effect of Cyr61 in Urinary Tract Transitional Cell Carcinoma

Conditions: Carcinoma, Transitional Cell